Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Boin

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Investigation|February 17, 2026
A CD57+ CD8 T cell subset links cytotoxic T cell cytotoxicity to fibrotic lung disease in systemic sclerosisTakanori Sasaki, Ye Cao, John M Sowerby, et al.
Science (New York, N.Y.)|December 7, 2013
Association of the autoimmune disease scleroderma with an immunologic response to cancerChristine G Joseph, Erika Darrah, Ami A Shah, et al.
Chest|June 21, 2017
Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL ModelJulie Morisset, Eric Vittinghoff, Brett M Elicker, et al.
Nature Communications|October 24, 2017
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosisCristiano Sacchetti, Yunpeng Bai, Stephanie M Stanford, et al.
JCI Insight|December 27, 2016
Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severityShane Lofgren, Monique Hinchcliff, Mary Carns, et al.
Journal of Scleroderma and Related Disorders|February 2, 2019
Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group ReportJohn D Pauling, Tracy M Frech, Michael Hughes, et al.
Annals of the Rheumatic Diseases|July 17, 2024
Racial variability in immune responses only partially explains differential systemic sclerosis disease severityKamini E Kuchinad, Ji Soo Kim, Adrianne Woods, et al.
Medicine|February 3, 2018
Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical databaseNadia D Morgan, Ami A Shah, Maureen D Mayes, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2018
Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African AmericansPravitt Gourh, Elaine F Remmers, Steven E Boyden, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2019
<i>HLA</i> and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicryPravitt Gourh, Sarah A Safran, Theresa Alexander, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Investigation|February 17, 2026
A CD57+ CD8 T cell subset links cytotoxic T cell cytotoxicity to fibrotic lung disease in systemic sclerosisTakanori Sasaki, Ye Cao, John M Sowerby, et al.
Science (New York, N.Y.)|December 7, 2013
Association of the autoimmune disease scleroderma with an immunologic response to cancerChristine G Joseph, Erika Darrah, Ami A Shah, et al.
Chest|June 21, 2017
Mortality Risk Prediction in Scleroderma-Related Interstitial Lung Disease: The SADL ModelJulie Morisset, Eric Vittinghoff, Brett M Elicker, et al.
Nature Communications|October 24, 2017
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosisCristiano Sacchetti, Yunpeng Bai, Stephanie M Stanford, et al.
JCI Insight|December 27, 2016
Integrated, multicohort analysis of systemic sclerosis identifies robust transcriptional signature of disease severityShane Lofgren, Monique Hinchcliff, Mary Carns, et al.
Journal of Scleroderma and Related Disorders|February 2, 2019
Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group ReportJohn D Pauling, Tracy M Frech, Michael Hughes, et al.
Annals of the Rheumatic Diseases|July 17, 2024
Racial variability in immune responses only partially explains differential systemic sclerosis disease severityKamini E Kuchinad, Ji Soo Kim, Adrianne Woods, et al.
Medicine|February 3, 2018
Clinical and serological features of systemic sclerosis in a multicenter African American cohort: Analysis of the genome research in African American scleroderma patients clinical databaseNadia D Morgan, Ami A Shah, Maureen D Mayes, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2018
Brief Report: Whole-Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African AmericansPravitt Gourh, Elaine F Remmers, Steven E Boyden, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 25, 2019
<i>HLA</i> and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicryPravitt Gourh, Sarah A Safran, Theresa Alexander, et al.
Pageof 7